CompletedNCT01429272
Minocycline and Aspirin for Depression Related to Bipolarity
About this title
Read the official source — NCT01429272Medication studyAges 18–65United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Wichita and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateSeptember 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 99
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01429272
- Official title
Show the full official title
Minocycline and Aspirin in the Treatment of Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Wichita · Tulsa
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Laureate Institute for Brain Research, Inc., a research institute.
Did this study involve medication?
Yes. The study involved medication, including Minocycline, Aspirin and placebo.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
